Related Experiment Video
Updated: Jun 4, 2026
06:15
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Infiltrative lung diseases in pregnancy
N Freymond1, V Cottin1, J F Cordier1
1Department of Respiratory Medicine, Reference Centre for Rare Pulmonary Diseases, Hospices Civils de Lyon, Louis Pradel Hospital, Lyon, France; University of Lyon I, UMR754 INRA, IFR 128, Lyon, France.
Clinics in Chest Medicine
|February 1, 2011
Summary
Pregnancy can impact infiltrative lung disease (ILD) diagnosis and outcomes, and ILD can affect pregnancy. Preexisting ILD requires careful pre-pregnancy evaluation for safe management.
Area of Science:
- Pulmonology and Obstetrics
Background:
- Infiltrative lung disease (ILD) can complicate pregnancy, affecting both maternal and fetal outcomes.
- Pregnancy itself may influence the presentation and progression of ILD.
- Certain medications used during pregnancy can induce or exacerbate ILD.
Purpose of the Study:
- To review the complex interplay between pregnancy and infiltrative lung disease.
- To outline diagnostic and management considerations for ILD in pregnant patients.
- To assess the impact of ILD on pregnancy outcomes and vice versa.
Main Methods:
- Literature review of studies investigating ILD in pregnancy.
- Analysis of case reports and clinical series.
- Synthesis of current guidelines and expert opinions.
Main Results:
- ILD is rare in pregnancy due to typical age demographics, but can arise de novo or worsen existing conditions.
- Some ILDs may not significantly alter pregnancy management, labor, or delivery.
- Preexisting ILD is not an absolute contraindication to pregnancy but necessitates comprehensive pre-conception assessment.
Conclusions:
- Careful pre-pregnancy evaluation is crucial for identifying contraindications and tailoring monitoring for pregnant individuals with ILD.
- Management strategies must be individualized based on ILD type, severity, and pregnancy stage.
- Further research is needed to optimize the care of pregnant patients with ILD.
Related Concept Videos
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...